MEI Pharma put money for Litecoin, make LTC jump 7%
Canadian oncology company MEI Pharma don put beta cash dem wey dem get for Litecoin, buy like 700,000 LTC tokens for average price of $150 per coin. Before reports talk say dem get 930,000 LTC, wey be like 60% of their treasury. The CFO talk say Litecoin quick settlement and strong liquidity na the main things wey make am good for corporate crypto treasury management.
Dis move follow big pattern wey nonfinancial public companies dey use to plus their options from fiat, after MicroStrategy Bitcoin plan. After MEI Pharma announce, LTC price jump 7%, show say market dey positive. Traders suppose dey observe changes wey fit happen for Litecoin market liquidity and price wahala as institutional people dey adopt am more.
MEI Pharma plan to dey report their crypto holdings from time to time and fit add other digital assets. More corporate treasury money wey go enter Litecoin fit boost LTC trading volume and market size for long term.
Bullish
Di tin dey allocate treasury funds to Litecoin na one big institutional adoption matter. For short term, MEI Pharma buy cause price for LTC rise by 7%, as traders dem react well say one big public company don enter market. Dis surge fit come with high volatility and wan shift in liquidity as big holdings waka inside and outside exchanges. For long term, regular crypto holdings disclosure and possible expansion to other digital assets fit ginger investor confidence. Historical cases like MicroStrategy Bitcoin strategy show say sustained corporate treasury allocation fit support steady price growth. Since Litecoin get strong network liquidity and fast settlement, dis move go likely support steady bullish momentum for LTC.